Skip to content

Effects of lidocaine and dexmedetomidine on the dosage of sufentanil in thoracic surgery under the guidance of surgical plethysmography index (SPI)

Effects of lidocaine and dexmedetomidine on the dosage of sufentanil in thoracic surgery under the guidance of surgical plethysmography index (SPI)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059253
Enrollment
Unknown
Registered
2022-04-27
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frugal opioids

Interventions

Dexmedetomidine group:Ten minutes before anesthesia induction, dexmedetomidine 0.5 UG / kg was injected intravenously, then 20 ml syringe was put into the amount of 0.2 UG / kg / h, normal saline was
lidocaine group:Ten minutes before anesthesia induction, lidocaine 1mg / kg was injected intravenously, then 20ml syringe was put into the amount of 1mg / kg / h, normal saline was diluted to 20ml, an
Normal saline group:Ten minutes before anesthesia induction, normal saline of the same volume was injected intravenously, and then pumped continuously at the speed of 20ml / h until the end of the ope

Sponsors

The First Affiliated Hospital of Suzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Those who have obtained informed consent; 2. ASA grade I~II; 3. Age 18-65; 4. BMI18-25 kg/m2; 5. It is planned to perform lung wedge resection and segmental or lobectomy under single-hole thoracoscope.

Exclusion criteria

Exclusion criteria: 1. Including difficulty in inserting double-lumen bronchial catheter; Hypertension patients; 2. History of drug use that may affect autonomic nervous regulation, such as ß- Receptor blocker or clonidine; 3. Serious cardiopulmonary disease (pacemaker implantation, atrial fibrillation); 4. Bradycardia (heart rate<60 beats/min); 5. Endocrine diseases (diabetes, thyroid dysfunction); 6. Peripheral neuropathy or terminal cold; Abnormal liver and kidney function; 7. Have a history of abuse of opiates or other analgesics; 8. Contraindications of lidocaine and flurbiprofen ester; 9. Changes in surgical procedures; Atropine or other cardiovascular drugs are required during surgery.

Design outcomes

Primary

MeasureTime frame
Dosage of sufentanil during and after operation;

Secondary

MeasureTime frame
Hemodynamic changes;Time of extubation in recovery room after operation;NRS pain score after conscious extubation and pain score at 4, 8, 12 and 24 hours after operation;

Countries

China

Contacts

Public ContactJi Fuhai

Changshu Second People's Hospital

Jifuhai@hotmail.com+86 13656207331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026